Sector: Health Care
Director information for CERUS CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Ann Lucena | Chief Executive Officer, Healthcare Advisory Hub, LLC | 39 | ["Senior healthcare provider leadership","Accounting/financial reporting","Finance/capital management and allocation","Risk oversight/risk management"] | [] | 2026 |
| Dean Gregory | Director, Cerus Corporation | 57 | ["Accounting/financial reporting","Strategic planning","Senior leadership experience","Risk oversight/risk management"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Eric Bjerkholt | Chief Financial Officer, Mirum Pharmaceuticals, Inc.; Director | 66 | ["Accounting/financial reporting","Global life sciences business experience","Strategic planning","Public company boards experience"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Frank Witney, Ph.D. | Operating Partner, Ampersand Capital Partners; Director | 72 | ["Strategic planning","Global life sciences business experience","Industry experience/regulatory/FDA","Senior leadership experience"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Hua Shan, M.D. | Professor and Medical Director of Transfusion Medicine Service, Stanford University Medical Center | 65 | [] | [] | 2026 |
| Hua Shan, MD, Ph.D. | Director | ["Industry experience/regulatory/FDA – extensive expertise and experience regarding international blood transfusion practice and safety","Scientific – leading expert on international transfusion practice and blood transfusion safety, member of editorial boards of several leading international journals including Transfusion and Transfusion Medicine Review and has contributed to over one hundred publications in the field of blood transfusion practice","Research/discovery – extensive research experience, including as Principal Investigator for the NHLBI sponsored REDS-II and REDS-III studies","Government affairs/public policy – experience as director of Johns Hopkins University’s U.S. National Institutes of Health Fogarty International Blood Safety Program"] | [] | 2026 | |
| Jami Dover Nachtsheim | Director, Cerus Corporation | 67 | ["Sales/marketing – extensive experience bringing high technology products to market through her roles at Intel Corporation","International markets – extensive experience driving business success in markets around the world through her roles at Intel Corporation","Public company boards – insight that enhances her value to our Board gained through experience on the boards of directors of other public companies","Senior leadership – leadership experience, including as Corporate Vice President of the Sales and Marketing Group and as Director of Worldwide Marketing at Intel Corporation and as Chair of the board of directors of Affymetrix"] | [] | 2026 |
| William M. Greenman | President, Chief Executive Officer and Board Chair, Cerus Corporation | 59 | ["Strategic planning","Corporate development experience","Global life sciences business","Risk oversight/risk management","Industry experience/regulatory/FDA"] | [] | 2026 |
